Signaling Pathway
Silevimig is a monoclonal antibody specifically targeting the rabies virus (RABV). This antibody binds to the viral surface proteins, neutralizing the virus and preventing its propagation. Silevimig is utilized extensively in research focusing on the development of rabies treatments and vaccines, and in studies exploring the pathophysiology of this virus.
重要通知：仅供研究使用。我们不向患者销售。
| Discription | Silevimig is a monoclonal antibody specifically targeting the rabies virus (RABV). This antibody binds to the viral surface proteins, neutralizing the virus and preventing its propagation. Silevimig is utilized extensively in research focusing on the development of rabies treatments and vaccines, and in studies exploring the pathophysiology of this virus. |
||
|---|---|---|---|
| Targets |
|
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
